The price-to-earnings ratio for Invesco Ltd (NYSE: IVZ) is above average at 11.52x. The 36-month beta value for IVZ is also noteworthy at 1.45. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 12 rating it as “hold,” and 1 rating it as “sell.”
The public float for IVZ is 443.93M, and at present, short sellers hold a 3.30% of that float. The average trading volume of IVZ on June 03, 2025 was 5.94M shares.
IVZ) stock’s latest price update
The stock of Invesco Ltd (NYSE: IVZ) has decreased by -0.55 when compared to last closing price of 14.46. seekingalpha.com reported 2025-05-23 that I use YCharts’ Value Score and Ben Graham Formula to identify large-cap stocks offering strong value relative to profits, assets, and dividends. Eighteen of twenty-four ‘safer’ lowest-priced Dividend Dogs of the GVAS are fair-priced and ready to buy for income-focused investors. Top ten GVAS stocks are projected to deliver 17.99% to 68.74% net gains by May 2026, with average risk 29% below the market.
IVZ’s Market Performance
Invesco Ltd (IVZ) has experienced a 0.00% fall in stock performance for the past week, with a 3.30% rise in the past month, and a -14.20% drop in the past quarter. The volatility ratio for the week is 1.74%, and the volatility levels for the past 30 days are at 1.96% for IVZ. The simple moving average for the last 20 days is -3.11% for IVZ stock, with a simple moving average of -13.49% for the last 200 days.
Analysts’ Opinion of IVZ
Many brokerage firms have already submitted their reports for IVZ stocks, with TD Cowen repeating the rating for IVZ by listing it as a “Hold.” The predicted price for IVZ in the upcoming period, according to TD Cowen is $13 based on the research report published on April 09, 2025 of the current year 2025.
Wells Fargo, on the other hand, stated in their research note that they expect to see IVZ reach a price target of $16. The rating they have provided for IVZ stocks is “Underweight” according to the report published on September 12th, 2024.
Barclays gave a rating of “Equal Weight” to IVZ, setting the target price at $18 in the report published on August 27th of the previous year.
IVZ Trading at 0.39% from the 50-Day Moving Average
After a stumble in the market that brought IVZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.45% of loss for the given period.
Stock Fundamentals for IVZ
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.48 for the gross margin
The net margin for Invesco Ltd stands at 0.13. The total capital return value is set at 0.03. Equity return is now at value 5.50, with 2.86 for asset returns.
Currently, EBITDA for the company is 1.24 billion with net debt to EBITDA at -1.52. When we switch over and look at the enterprise to sales, we see a ratio of 0.75. The receivables turnover for the company is 7.7for trailing twelve months and the total asset turnover is 0.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.
Conclusion
In summary, Invesco Ltd (IVZ) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
